Pridopidine for the Treatment of ALS—Results from the Phase 2 Healey ALS Platform Trial (S5.003)
医学
作者
Jeremy M. Shefner,Björn Oskarsson,Yaël Cohen,Kelly Chen,Melanie Leitner,James Berry,Eric A. Macklin,Lori B. Chibnik,Lindsay Pothier,Michal Geva,Paul Goldberg,Michael R. Hayden,Sabrina Paganoni,Merit Cudkowicz
出处
期刊:Neurology [Lippincott Williams & Wilkins] 日期:2024-04-09卷期号:102 (17_supplement_1)
标识
DOI:10.1212/wnl.0000000000206526
摘要
Pridopidine was evaluated in the Phase 2 HEALEY ALS Platform Trial.